Table 1.
Clinical characteristics | Total (445) | Percent (%) | ||
---|---|---|---|---|
Age at diagnosis (years) | <58 | 217 | 48.76 | |
≥58 | 228 | 51.24 | ||
Gender | Female | 168 | 37.75 | |
Male | 277 | 62.25 | ||
Fustat | Live | 207 | 47.09 | |
Death | 238 | 52.91 | ||
Clinical stage | 0 | 6 | 1.49 | |
I | 77 | 19.15 | ||
II | 130 | 32.34 | ||
III | 169 | 42.04 | ||
IV | 20 | 4.98 | ||
T stage | Tis | 7 | 1.74 | |
T0 | 23 | 5.72 | ||
T1 | 66 | 16.42 | ||
T2 | 76 | 18.91 | ||
T3 | 88 | 21.89 | ||
T4 | 142 | 35.32 | ||
Distant metastasis | Negative | 400 | 95.01 | |
Positive | 21 | 4.99 | ||
Lymph nodes | Negative | 221 | 55.67 | |
Positive | 1 | 73 | 18.39 | |
2–3 | 49 | 12.34 | ||
≥4 | 54 | 13.60 |
SKCM – skin cutaneous melanoma; TCGA – The Cancer Genome Atlas. The median age at diagnosis was 58 years old.